IL207859A - A combination of cancer treatment preparations - Google Patents

A combination of cancer treatment preparations

Info

Publication number
IL207859A
IL207859A IL207859A IL20785910A IL207859A IL 207859 A IL207859 A IL 207859A IL 207859 A IL207859 A IL 207859A IL 20785910 A IL20785910 A IL 20785910A IL 207859 A IL207859 A IL 207859A
Authority
IL
Israel
Prior art keywords
cancer agents
combination anti
combination
cancer
agents
Prior art date
Application number
IL207859A
Other languages
English (en)
Hebrew (he)
Other versions
IL207859A0 (en
Inventor
Luigi Lenaz
Guru Reddy
Original Assignee
Spectrum Pharmaceuticals Inc
Luigi Lenaz
Guru Reddy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc, Luigi Lenaz, Guru Reddy filed Critical Spectrum Pharmaceuticals Inc
Publication of IL207859A0 publication Critical patent/IL207859A0/en
Publication of IL207859A publication Critical patent/IL207859A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL207859A 2008-02-29 2010-08-29 A combination of cancer treatment preparations IL207859A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3283108P 2008-02-29 2008-02-29
PCT/US2009/034629 WO2009108573A1 (en) 2008-02-29 2009-02-20 Combination anti-cancer agents

Publications (2)

Publication Number Publication Date
IL207859A0 IL207859A0 (en) 2010-12-30
IL207859A true IL207859A (en) 2015-09-24

Family

ID=40566524

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207859A IL207859A (en) 2008-02-29 2010-08-29 A combination of cancer treatment preparations

Country Status (13)

Country Link
US (1) US20090221615A1 (enExample)
EP (1) EP2257285A1 (enExample)
JP (1) JP5590560B2 (enExample)
KR (1) KR20100126453A (enExample)
CN (1) CN102014895A (enExample)
AU (1) AU2009219464B2 (enExample)
BR (1) BRPI0908398A2 (enExample)
CA (1) CA2717100A1 (enExample)
IL (1) IL207859A (enExample)
MX (1) MX2010009502A (enExample)
RU (1) RU2516027C2 (enExample)
WO (1) WO2009108573A1 (enExample)
ZA (1) ZA201006123B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789895C (en) * 2010-03-08 2019-04-09 Spectrum Pharmaceuticals, Inc. Thioxanthone-based autophagy inhibitor therapies to treat cancer
EP2425830A1 (en) 2010-09-03 2012-03-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synergistic drug combination for the treatment of cancer
AU2022415337A1 (en) * 2021-12-14 2024-08-01 Daniel Pierce RADIN Compositions and methods for treating cancers of the central nervous system (cns), including glioblastoma and chemoresistant cns tumors, and related compositions and methods for inhibiting and eliminating cns cancer stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2252865T3 (es) * 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
US6391911B1 (en) * 1999-02-26 2002-05-21 Robert E. Bases Coadministration of lucanthone and radiation for treatment of cancer
PL1971338T3 (pl) * 2005-12-22 2011-07-29 Astrazeneca Ab Połączenie ZD6474 i premetreksedu
CA2631676A1 (en) * 2005-12-22 2007-06-28 Astrazeneca Ab Combination of azd2171 and pemetrexed

Also Published As

Publication number Publication date
RU2516027C2 (ru) 2014-05-20
CA2717100A1 (en) 2009-09-03
BRPI0908398A2 (pt) 2015-08-11
AU2009219464B2 (en) 2015-04-09
JP5590560B2 (ja) 2014-09-17
CN102014895A (zh) 2011-04-13
IL207859A0 (en) 2010-12-30
JP2011513315A (ja) 2011-04-28
MX2010009502A (es) 2010-11-10
EP2257285A1 (en) 2010-12-08
RU2010139840A (ru) 2012-04-10
US20090221615A1 (en) 2009-09-03
AU2009219464A1 (en) 2009-09-03
ZA201006123B (en) 2011-05-25
KR20100126453A (ko) 2010-12-01
WO2009108573A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
PL2918172T3 (pl) Połączenia środków kontroli biologicznej i fungicydów
PL2323992T3 (pl) 5-alkinylo-pirymidyny
GB0801600D0 (en) Microtrench
EP2233305A4 (en) GRAPHIC PRINTER
IL212375A0 (en) Naphthamides as anticancer agents
GB0801589D0 (en) Mollusicide
IL207859A0 (en) Combination anti-cancer agents
EP2268146A4 (en) ANTICANCER AGENTS BASED ON INDOLINE
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
GB0901480D0 (en) Contrast agents
GB0823130D0 (en) Construction member
GB0810062D0 (en) Threapeutic agents
AU3977P (en) PARV01 Myoporum parvifolium
AU4098P (en) NPW2 Dianella tasmanica
AU3935P (en) DPV308 Dianella prunina
AU3972P (en) Tobruk xTriticosecale
GB0809856D0 (en) Anti-cancer combination therapy
IL192531A0 (en) Watch-bluetooth combination
GB0810552D0 (en) Combination
GB0804837D0 (en) Concept three
GB0808841D0 (en) Novel anti-cancer combination therapy
GB0808765D0 (en) Location
GB0723750D0 (en) Therapeutuic agents
GB0803752D0 (en) Photobiofermenter

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees